Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132188) titled 'Treatment status and factors influencing treatment attainment in patients with pulmonary arterial hypertension in China: a mixed-method study of physicians and patients' on Sept. 10.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Fuwai Hospital, Chinese Academy of Medical Sciences
Condition:
Pulmonary arterial hypertension
Intervention:
PAH expert:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-14
Target Sample Size: PAH expert:75;Patients with PAH:550;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org....